LDL

[ANMCO Expert opinion: Bempedoic acid place in therapy for hypercholesterolemia management]

40 views | Oct 24 2023

Bempedoic acid, a newly approved therapeutic option for hypercholesterolemia, offers a hepatic selective action that reduces the risk of muscle adverse effects, making it particularly useful in certain clinical settings according to an ANMCO document. [Read the Full Post]

Structure-based mechanism and inhibition of cholesteryl ester transfer protein

36 views | Apr 02 2023

Recent research on cholesteryl ester transfer proteins (CETP) has highlighted their role in regulating plasma cholesterol levels and their potential as a therapeutic target for ASCVD or dyslipidemia, with ongoing research focusing on the structural and mechanistic basis of CETP inhibition to guide the development of more effective anti-ASCVD therapeutics. [Read the Full Post]